Understanding Your Laboratory Test: What It Is, Why It Is Done, and How to Read Your Results

What is this test and what does it check for?

The Amphetamines in Meconium test is a diagnostic test that detects whether a baby has been exposed to amphetamine drugs (such as methamphetamine or ADHD medications) while in the womb. Meconium is the baby's first stool, which begins to form around the 12th week of pregnancy and accumulates until birth. Because drugs and their metabolites can cross the placenta and enter the amniotic fluid, they become incorporated into the meconium as the baby swallows amniotic fluid. This makes meconium testing particularly useful for detecting drug exposure that occurred during the second and third trimesters of pregnancy.

Why might my doctor order this test for me?

This test is typically ordered when healthcare providers suspect that a pregnant person may have used amphetamine-type drugs during pregnancy. Risk factors include lack of prenatal care, history of substance use, certain social or behavioral concerns, or positive drug screens in the mother. The test helps healthcare teams identify babies who may need special monitoring or care due to prenatal drug exposure, including potential withdrawal symptoms (Neonatal Abstinence Syndrome). Early identification allows for prompt intervention and appropriate support services for both the baby and family.

How is the sample collected, and what can I expect during the process?

The sample is collected from the baby's first bowel movements, called meconium. This is typically collected from the diaper within the first 24-72 hours after birth. The sample is then sent to a laboratory where it undergoes testing using confirmatory methods (such as mass spectrometry) to accurately identify the presence of amphetamines and related compounds. This confirmatory approach provides highly reliable results compared to initial screening tests.

What do my test results mean, and how will my doctor explain them to me?

A positive result indicates that the baby was exposed to amphetamines during pregnancy. The healthcare team will use this information to develop an appropriate care plan, which may include monitoring for withdrawal symptoms, providing specialized feeding support, and connecting the family with appropriate resources. A negative result means no amphetamines were detected in the meconium sample, though it does not absolutely rule out all drug exposure (particularly in early pregnancy). It's important to discuss your specific results with your healthcare provider who can explain what they mean for your baby's care.